Search

Your search keyword '"Renard, V."' showing total 375 results

Search Constraints

Start Over You searched for: Author "Renard, V." Remove constraint Author: "Renard, V."
375 results on '"Renard, V."'

Search Results

1. Superconductivity of alpha-gallium probed on the atomic scale by normal and Josephson tunneling

2. Giant atomic swirl in graphene bilayers with biaxial heterostrain

3. Observation of Kekul\'e vortices induced in graphene by hydrogen adatoms

4. Atomic-layer controlled THz Spintronic emission from Epitaxially grown Two dimensional PtSe$_2$/ferromagnet heterostructures

5. Heterostrain rules the flat-bands in magic-angle twisted graphene layers

6. Measuring the Berry phase of graphene from wavefront dislocations in Friedel oscillations

7. Electronic spectrum of twisted graphene layers under heterostrain

8. Epitaxial electrical contact to graphene on SiC

9. Internet Use and its Effect on Selected Grade 12 HUMSS Students at Bestlink College of the Philippines: Vol.3, No.1D

10. Metallic behaviour in SOI quantum wells with strong intervalley scattering

11. Valley polarization assisted spin polarization in two dimensions

12. Coulomb pseudogap in elastic 2D-2D electron tunneling in a quantizing magnetic field

13. Quantum corrections to the conductivity and Hall coefficient of a two-dimensional electron gas in a dirty AlGaAs/GaAs/AlGaAs quantum well: from the diffusive to the ballistic regime

14. Conductivity of a 2DEG in Si/SiGe heterostructure near metal- insulator transition: role of the short and long range scattering potential

15. Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1.

16. Patient (pt) reported pain and health-related quality of life (HRQoL) by genomic loss of heterozygosity (gLOH) status in men with metastatic castration-resistant prostate cancer (mCRPC) receiving talazoparib (TALA): TALAPRO-1

22. Patient-reported pain by baseline pain status in men with metastatic Castration-Resistant Prostate Cancer (mCRPC) receiving Talazoparib (TALA): TALAPRO-1

23. Health-Related Quality of Life (HRQoL) in men with metastatic Castration-Resistant Prostate Cancer (mCRPC) receiving Talazoparib (TALA): TALAPRO-1

25. L'Escarpement de Malte, le mont Alfeo et les monts de Médine: marges anciennes du bassin Ionien (synthèse des données des campagnes a la mer Escarmed) Malta Escarpment, Alfeo and Medina Seamounts: Former Margins of the Ionian Basin

27. 581P Patient (pt) reported pain in men with metastatic castration-resistant prostate cancer (mCRPC) receiving talazoparib (TALA): TALAPRO-1

28. 580P TALAPRO-1: Talazoparib (TALA) monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) - Exploration of non-DDR mutational landscape and potential associations with antitumor activity

29. OC-0625 Immuno-radiotherapy in solid tumors: preliminary results of the randomized phase 2 CHEERS trial

36. 138P TALAPRO-1: Talazoparib (TALA) monotherapy in men with DNA damage response alterations (DDRalt) and metastatic castration-resistant prostate cancer (mCRPC): Exploration of DDRalt germline/somatic origin

40. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

45. Abstract P2-08-47: Evaluation of stromal tumor-infiltrating lymphocytes (sTIL) and tertiary lymphoid structures (TLS) in early breast cancer patients with triple negative breast cancer(TNBC) included in a prospective study of neoadjuvant chemotherapy (NAC) with Epirubicin and cyclophosphamide (EC) and carboplatin-paclitaxel (PC) (BSMO 2014-01)

50. Neoadjuvant weekly carboplatin and paclitaxel followed by dose dense epirubicin and cyclophosphamide in triple negative breast cancer patients

Catalog

Books, media, physical & digital resources